Shamburg News · 8-K filed Oct 6, 2026, 8:05 AM EDT

PDS Biotechnology to Host Key Opinion Leader Event on PDS0301 for Liver-Associated Cancers

PDSB · PDS Biotechnology Corp

  • Other event
  • Materiality: low

On October 6, 2026, PDS Biotechnology Corporation announced it will host a virtual key opinion leader event on October 15, 2026, at 8:00 AM ET featuring Jonathan M. Hernandez, M.D., an investigator with the National Cancer Institute's Center for Cancer Research. The event will discuss clinical outcomes from the PDS0301 Phase 2 trials for advanced liver-associated cancers, with a focus on the metastatic colorectal cancer cohort. The announcement was furnished as Exhibit 99.1.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Items 8.01, 9.01, accession 0001140361-26-038728.

Written from the filing by Shamburg Markets. Figures are as reported by the company.